Literature DB >> 24271471

Development of Interferon Suppositories. I. Enhanced Rectal Absorption of Human Fibroblast Interferon by Fusogenic Lipid via Lymphotropic Delivery in Rats.

H Yoshikawa1, K Takada, Y Satoh, N Naruse, S Muranishi.   

Abstract

We attempted to enhance the rectal absorption of human fibroblast interferon (HuIFN-β) in rats by the administration of suppositories containing fusogenic lipid and a nontoxic surfactant. Suppositories containing either the lipid (linoleic acid) or the surfactant [HCO60; polyoxyethylated (60 mol) hydrogenated castor oil] alone failed to enhance the absorption of HuIFN-β. However, suppositories containing both linoleic acid and HCO60 facilitated the rectal absorption of HuIFN-β. The absorbed HuIFN-β was selectively delivered via the lymph.

Entities:  

Year:  1986        PMID: 24271471     DOI: 10.1023/A:1016349605061

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  5 in total

1.  Potential absorption of heparin from the small intestine and the large intestine in the presence of monoolein mixed micelles.

Authors:  S Muranishi; Y Tokunaga; K Taniguchi; H Sezaki
Journal:  Chem Pharm Bull (Tokyo)       Date:  1977-05       Impact factor: 1.645

2.  Circulating interferon in rabbits after administration of human interferon by different routes.

Authors:  K Cantell; L Pyhälä
Journal:  J Gen Virol       Date:  1973-07       Impact factor: 3.891

3.  A method to potentiate enteral absorption of interferon and selective delivery into lymphatics.

Authors:  H Yoshikawa; K Takada; S Muranishi; Y Satoh; N Naruse
Journal:  J Pharmacobiodyn       Date:  1984-01

4.  Comparison of disappearance from blood and lymphatic delivery of human fibroblast interferon in rat by different administration routes.

Authors:  H Yoshikawa; Y Satoh; N Naruse; K Takada; S Muranishi
Journal:  J Pharmacobiodyn       Date:  1985-03

5.  Potentiation of enteral absorption of human interferon alpha and selective transfer into lymphatics in rats.

Authors:  H Yoshikawa; K Takada; Y Satoh; N Naruse; S Muranishi
Journal:  Pharm Res       Date:  1985-09       Impact factor: 4.200

  5 in total
  1 in total

1.  Recombinant human interferon alpha-2a: delivery to lymphoid tissue by selected modes of application.

Authors:  A Supersaxo; W Hein; H Gallati; H Steffen
Journal:  Pharm Res       Date:  1988-08       Impact factor: 4.200

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.